We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Can a Robot Be Taught to Trim Cannabis?

Can a robot trim marijuana better than a human? One company thinks so. In this feature, Analytical Cannabis caught up with Jon Gowa, CEO of Bloom Automation, to find out just how a bot is trained to cut around bud.

Read More

What a Democrat-led Senate Means for Cannabis Legalization

Does Democratic control of both houses of Congress mean legalization is around the corner?

Read More

Colorado Regulators Recall Cannabis Products Due to Mold Contamination

Any consumer in possession of such a product has been advised by the Colorado Department of Revenue to return it to the initial retailer.

Read More

UK Regulator Grants Second Commercial License to Grow Medical Cannabis

The Jersey-based company has become the second cultivator in the British Isles to be licensed by the UK Home Office to grow pharmaceutical-grade cannabis for profit.

Read More

FDA Outlines Plan to Improve CBD Research Data

The administration said it intends to use poison control records and other databases to better identify CBD products associated with adverse events. A new opt-in registry for CBD consumers is also in the works.

Read More

How Cannabis Interacts With Psychedelics

As progressive reform slowly arrives to cannabis and psychedelics possession, attention will inevitably be given to how the substances can interact. So, what do we already know?

Read More

Young Medical Cannabis Patients More Likely to Experience Withdrawal Symptoms, Finds Study

Following a two-year longitudinal study, the researchers concluded that cannabis withdrawal should be considered on a scale of severity, rather than as distinct subtypes of withdrawal syndromes.

Read More

Oregon Regulators Recall Pesticide-contaminated Cannabis Products

The adult-use cannabis extracts and pre-rolls initially failed state testing requirements and are considered unsafe for consumers.

Read More

Add-on CBD Reduces Seizures in Patients With Tuberous Sclerosis, Study Finds

The clinical trial found that Epidiolex can reduce the number of seizures in patients with tuberous sclerosis complex (TSC) by around 50 percent, compared to baseline levels.

Read More

 
Advertisement